small molecule

NAPHCON-A

NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE

Loss of exclusivity—loss of exclusivity

CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand name	NAPHCON-A
Active ingredient	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Strength	0.025%;0.3%
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	June 1994
Marketing status	OTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.